encapsulated liposome (Doxil) has been approved by FDA for ovarian cancer and Kaposi’s sarcoma treatment in United States. However, the researches are still going on to optimize the liposomes
utilized to treat various cancers, including gastric, breast, thyroid, ovarian, lung, bladder, liver, sarcoma, and pediatric cancers. On the other hand, DOX can cause cardiotoxic effects forcing patients to discontinue
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.